June 28, 2025

Survey Study Highlights Positive Impacts of Continuous Subcutaneous Apomorphine Infusion in Confidence for Everyday Activities

Continuous subcutaneous apomorphine infusion enhances confidence and reduces treatment burden for Parkinson’s patients, improving daily activity engagement.

June 27, 2025

Parkinson’s may begin decades earlier — and your immune system might know first – ScienceDaily

June 27, 2025

Phase 2 SUNRISE-PD Trial to Test BioVie‘s Bezisterim for Early-Stage Parkinson Disease

The design of a phase 2 study, presented at ATMRD 2025, highlighted the trial’s patient-focused approach, allowing patients with Parkinson disease to complete visits either at home or in a clinic.

June 27, 2025

Movement-responsive deep brain stimulation for Parkinson’s disease using a remotely optimized neural decoder – Nature

June 27, 2025

Patient and Clinician Perspectives on Empathy in Parkinson Disease Care: Daniel Irizarry, MD

The medical advisor at Tactical Medical Solutions shared insights from both clinical and personal perspectives on the importance of empathy and active listening in managing Parkinson disease. [WATCH TIME: 3 minutes]